| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:1032-1040.)
© 2007 American Heart Association, Inc.
Pediatric Cardiology |
From the Departments of Pediatrics (H.N., K.N.-S., O.S.), Medicine (T.R., J.V.), and Clinical Physiology (O.T.R.) and Research Centre of Applied and Preventive Cardiovascular Medicine (H.L., M.S.), University of Turku, Turku; National Public Health Institute, Turku (A.J., J.M.); and Department of Paediatrics, University of Helsinki, Helsinki (E.J.), Finland.
Reprint requests to Harri Niinikoski, MD, PhD, Department of Pediatrics, University of Turku, Kiinamyllynkatu 4–8, 20520 Turku, Finland. E-mail harri.niinikoski{at}tyks.fi
Received February 27, 2007; accepted June 15, 2007.
| Abstract |
|---|
|
|
|---|
Methods and Results— In the randomized prospective Special Turku Coronary Risk Factor Intervention Project (STRIP), a low-saturated-fat, low-cholesterol diet was introduced to intervention infants (n=540) at 7 months of age, and control children (n=522) received an unrestricted diet. Dietary intakes, serum cholesterol values, somatic growth, and development were followed up throughout childhood and adolescence. Saturated fat intakes, serum total cholesterol, and low-density lipoprotein cholesterol values were lower (P<0.001) in the intervention than in control children during the 14 years, whereas high-density lipoprotein cholesterol values in the 2 study groups showed no difference. Boys had lower total and low-density lipoprotein cholesterol concentrations than girls throughout childhood (P<0.001), and the intervention effect on serum cholesterol concentration was larger in boys than girls. The 2 study groups showed no difference in growth, body mass index, pubertal development, or age at menarche (median, 13.0 and 12.8 years in the intervention and control girls, respectively; P=0.52). The cholesterol values decreased as puberty progressed. Mean concentrations of total and high-density lipoprotein cholesterol decreased from
4.5 and
1.4 mmol/L, respectively, in Tanner stage 1 (prepubertal) boys to
3.9 and
1.1 mmol/L in Tanner stage 4 (late pubertal) boys.
Conclusions— Repeated dietary counseling remains effective in decreasing saturated fat and cholesterol intake and serum cholesterol values at least until 14 years of age. Puberty markedly influences serum cholesterol concentrations.
Key Words: cholesterol coronary disease nutrition pediatrics prevention
| Introduction |
|---|
|
|
|---|
Editorial p 973
Clinical Perspective p 1040
In the Special Turku Coronary Risk Factor Intervention Project (STRIP), a low-saturated-fat, low-cholesterol diet was introduced to healthy infants in the intervention group before their 1-year birthdays.7 We showed previously that such an early-onset counseling of saturated fat– and cholesterol-restricted diet decreased serum cholesterol concentrations successfully up to early school age8 with no assessable adverse effects.9 However, age >7 years creates new challenges in nutrition counseling because school-aged children and adolescents consume progressively more of their nutrient intakes away from home and peer pressure starts to influence food consumption. Furthermore, most children enter puberty at or around 11 years of age, which significantly modifies serum lipid and lipoprotein values in boys and girls.10 It is also worth noticing that cholesterol is a precursor of sex hormones, and indeed, in the Dietary Intervention Study in Children (DISC), serum estradiol and other sex hormone concentrations were lower in adolescent girls receiving dietary counseling to reduce intake of saturated fat and cholesterol than in control subjects.3
We have now investigated of the effects of low-saturated-fat, low-cholesterol dietary counseling on dietary intakes, growth, and serum lipid, lipoprotein, and apolipoprotein values until 14 years of age. We also prospectively measured the effect of such counseling and of the induced dietary changes on pubertal development. Finally, we examined in detail the serum lipid and lipoprotein changes occurring during progression of the pubertal stages between 10 and 14 years of age.
| Methods |
|---|
|
|
|---|
A nutritionist provided dietary counseling to the intervention families, and the child and family had an active role in the counseling sessions.7–9 The intervention was individualized for each child and aimed at achieving a fat intake of 30% to 35% of daily energy (E%), with a ratio of saturated to monounsaturated plus polyunsaturated fatty acid of 1:2 and cholesterol intake <200 mg/d. Breastfeeding or formula was advised during the first year of life; then, 0.5 to 0.6 L skim milk daily was recommended. To maintain adequate fat intake, the parents were taught to add daily 2 or 3 teaspoonfuls (10 g) of soft margarine or vegetable oil, mainly low-erucic-acid rapeseed oil, to the childs food from 12 to 24 months of age. Change in the type of milk was the major subject matter of the intervention during the first months of the trial. Because the counseling was individualized, the nutritionist used the childs recent food record as a basis for suggestions. The families were encouraged to gradually change the childs diet toward better fat composition. Ample use of vegetables, fruits, berries, and whole grain products was encouraged.
During the first years, the counseling was given primarily to the parents. However, beginning at 7 years of age, progressively more dietary information and suggestions were given directly to the child. The counseling was based on the age and cognitive ability of the child. Most of the material used was specially developed for the project because ready-made counseling materials for children are sparse. The parents were carefully informed about the counseling session and were encouraged to discuss the same food-related topics with the child at home.
The control children were seen biannually until 7 years of age and annually thereafter. They received the basic health education routinely given at Finnish well-baby clinics and through school health care. At 12 months of age, cows milk with 1.9% (1.5% after May 1995) fat was recommended for daily use. Dietary issues were discussed only superficially with control families.
Food consumption data were obtained through annual 4-day food records (3-day food records before 2 years of age).7,8 After a nutritionist reviewed the food records for accuracy, the nutrient intakes were calculated with software (Micro Nutrica, Turku, Finland) based on the Food and Nutrient Database of the Social Insurance Institution.11
Serum Lipid and Apolipoprotein Determinations
A venous blood sample was drawn for measurement of serum lipid and apolipoprotein concentrations at 7 months, 13 months, and 2 years of age and annually thereafter. All serum analyses were done at the laboratory of the National Public Health Institute in Turku, Finland.
After clotting at room temperature and low-speed centrifugation (at 3400g for 12 minutes), serum was separated and stored at –25°C for up to a few weeks. Serum cholesterol concentration was measured with a fully enzymatic cholesterol oxidase-p-aminophenazone method (CHOD-PAP, Merck, Darmstadt, Germany) in an AU 510 automatic analyzer (Olympus, Hamburg, Germany) or, after January 2001, an AU 400 analyzer. Calibration runs were performed for cholesterol, high-density lipoprotein (HDL) cholesterol, and apolipoprotein concentrations, and the results for samples analyzed before 2001 were corrected as follows: s-cholesterol=s-cholesterol (before 2001)x1.0207+0.0526; s–HDL-cholesterol=s–HDL-cholesterol (before 2001)x1.031–0.0083; s-ApoA-I=s–ApoA-I (before 2001)x1.0239+0.0991; and s-ApoB=s-ApoB (before 2001)x0.8725+0.1812, where s indicates serum and ApoA-I and ApoB indicate apolipoprotein A-I and B. Serum HDL cholesterol concentration was measured after precipitation of LDL and very LDL with dextran sulfate 500 000.12 The interassay (intra-assay) coefficients of variation for total cholesterol and HDL cholesterol were 2.0% (1.5%) and 1.9% (1.2%), respectively. ApoA-I and ApoB were determined immunoturbidimetrically with ApoA-I and B kits (Orion Diagnostica, Helsinki, Finland). The interassay (intra-assay) coefficients of variation of the ApoA-I and ApoB determinations were 3.0% (1.8%) and 4.5% (3.3%), respectively. Serum triglyceride values were analyzed with the colorimetric GPO-PAP method (Merck, Darmstadt, Germany) in an automatic Olympus AU 510 analyzer or, after January 2001, with an AU 400 analyzer; earlier values were corrected as follows: s-triglyceride=s-triglyceride (before 2001)x1.0247+0.0191.
The blood samples drawn before 5 years of age were nonfasting. From 5 years of age on, fasting blood samples were drawn, and the Friedewald formula13 was used to calculate the LDL cholesterol concentrations.
Anthropometric Measurements and Recording of the Pubertal Status
Weights of the children were measured to the nearest 0.1 kg and height to the nearest 0.1 cm. Recumbent lengths were recorded until 2 years of age; thereafter, standing heights were measured with a Harpenden stadiometer (Holtain, Crymych, UK). Weights and heights were plotted on the Finnish growth charts.14 Body mass index (BMI) was calculated as kilograms per meter squared. Pubertal status was recorded beginning at the age of 9 years. Breast tissue diameter and testicular length were measured with a ruler, and pubic hair development was estimated visually. The respective pubertal stages (M1 through M5 and P1 through P5 in girls; G1 through G5 and P1 through P5 in boys) were recorded according to well-established criteria.15 M2 stood for breast budding; G2 indicated testicular length of >20 mm (corresponding volume >3 mL). For dividing subjects to pubertal and prepubertal, children with P1/G1 or P1/M1 were considered prepubertal, and all others were considered pubertal. For allocating children to Tanner stages 1 through 5, Tanner stage 1 corresponded to G1 and M1, Tanner stage 2 for G2 and M2, Tanner stage 3 for G3 and M3, Tanner stage 4 for G4 and M4, and Tanner stage 5 for G5 and M5 in boys and girls, respectively.
Statistical Analyses
Repeated-measures ANOVA was conducted for lipid values, food intakes, and growth measures across the age points 7 months to 14 years. Multivariate repeated-measured ANCOVA models were used to adjust the intervention effect on serum lipid values with energy intake, saturated fatty acid intake (as E%), height (SD), and BMI. Lipid values from 10 to 14 years of age also were analyzed with repeated-measures ANOVA with Tanner puberty stage as the repeat factor. Because of skewed distribution, triglycerides, weight, and BMI were analyzed after logarithmic transformation. If a child stayed in a certain puberty stage for several years, his/her lipid values were averaged within the puberty stage for analyses. Sex and intervention group–with-interaction terms were included in all analyses; interactions with an observed significance level >0.1 were excluded from the final models. In case of significant interactions, pairwise comparisons between groups were accomplished by Bonferroni-corrected t tests to avoid the increase in type I error risk. For interaction containing age, the pairwise comparisons between groups and/or sexes were done at 9 and 14 years of age (ApoA-I and ApoB at 9 and 13 years), with 9 years representing prepubertal and 13 to 14 years representing pubertal age.
Differences in the proportion of pubertal children (puberty ongoing/prepubertal) between the intervention and control groups were analyzed with Cochran-Mantel-Haenszel method for general association stratified by sex. This same method also was used to examine whether M2 preceded P2 in girls pubertal development. Survival analysis was assessed for the age of menarche of the girls studied, with log-rank test for the pairwise comparison between intervention and control groups.
Results were considered statistically significant at values of P<0.05. Statistical analyses were performed with the SAS software for Windows, release 9.1 (SAS Institute, Cary, NC).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
|
|
Growth and Pubertal Progression
There were no differences in heights (P=0.44), weights (P=0.27), or BMIs (P=0.28) between the intervention and control groups (Table 1
and Figure 1). About 60% of the children had entered puberty by 11 years of age (Table 2). No differences existed in the pubertal progression between the study groups (P=0.19 in boys, P=0.12 in girls). M2 was the first sign of puberty in most girls, and there was no difference between the study groups in the proportion of girls who progressed to P2 before M2 (P=0.09). Age at menarche did not differ between intervention and control girls (P=0.52). The 25th percentile, median, and 75th percentile ages at menarche were 12.1, 13.0, and 13.6 years in the intervention girls and 12.0, 12.8, and 13.6 years in the control girls.
|
Serum Cholesterol, Lipoprotein, and Apolipoprotein Concentrations
The dietary intervention significantly influenced serum lipid and lipoprotein values throughout childhood (Figure 2). The difference between intervention and control children persisted in serum cholesterol through 14 years of age in boys (P<0.001), but the difference in girls was nonsignificant (P=0.12). There was a gender group interaction (P=0.043) in serum cholesterol; ie, the intervention influenced sexes differently. Boys had lower serum cholesterol and LDL cholesterol values than girls throughout childhood (P<0.001). Differences between groups were not seen in HDL cholesterol values. Boys had higher ratios of HDL to total cholesterol than girls (P<0.001). The effects of intervention and gender on ApoB values resembled those on LDL cholesterol, whereas changes in ApoA-1 resembled those in HDL values (data not shown). The ratio of ApoA-I to ApoB was higher in boys than in girls until adolescence (P between sexes <0.001 at 9 years; P=0.15 at 14 years of age), but there was no group difference (P=0.12). Serum triglyceride values were lower in boys than girls, but intervention had an effect on serum triglyceride values only in boys. Adjustment for energy intake, saturated fatty acid intake (as E%), height (SD), and BMI did not alter these results; the intervention effect remained significant on serum LDL concentration and HDL ratio in both genders and on serum cholesterol and triglyceride concentrations in boys, whereas it was not significant on HDL concentrations.
|
The peak of the mean serum cholesterol level was reached at 7 to 9 years of age. At 14 years of age, serum cholesterol concentrations had decreased to values observed at 7 months of age.
Serum Lipoprotein and Apolipoprotein Concentrations According to Pubertal Stage
The serum total, LDL, and HDL cholesterol values decreased as puberty progressed, especially in boys (Table 3). Prepubertal boys had higher ratios of HDL to cholesterol (0.30 to 0.31) than girls (0.28 to 0.29), but at late puberty, this ratio clearly was lower in boys (
0.25) than girls (
0.28). Pubertal changes in ApoA-I resembled those in HDL cholesterol, whereas ApoB changes resembled changes in LDL cholesterol (data not shown).
|
| Discussion |
|---|
|
|
|---|
Cholesterol values differed more between the intervention and control boys than girls. This gender difference cannot be explained by different adherence to the nutrition counseling because the saturated fat intake was significantly lower in both intervention boys and girls compared with control boys and girls, and adjustment for saturated fat intake did not alter this finding. The absolute serum cholesterol difference between the intervention and control boys was
0.2 mmol/L, ie,
5%. A larger decrease in serum cholesterol values in boys also may explain why the endothelial function improved in intervention compared with control boys but not in girls.5 Moreover, LDL cholesterol response to sitostanol margarine use also was greater in boys than girls.18 The reasons for the different serum lipid responses to the STRIP diet between genders remain unidentified, but divergent hormonal status, body composition, and physical exercise habits may all contribute to this outcome. Indeed, we previously showed19 that teenaged boys are physically more active than girls.
The effect of nutrition counseling on serum cholesterol concentrations in STRIP children was within the range achieved in previous studies in healthy children,20 whereas the decreases in serum LDL cholesterol values have been greater in hypercholesterolemic children.21 The results of STRIP intervention are unique because the lower serum cholesterol values were maintained from 1 to at least 14 years of age.
Serum cholesterol and HDL cholesterol concentrations were lower in the pubertal than prepubertal children, resembling serum lipid and lipoprotein changes induced by puberty reported earlier.10 The decreases in our study were of the same magnitude as in the DISC study, in which serum LDL cholesterol values decreased
0.6 mmol/L in boys and
0.3 mmol/L in girls when their Tanner stage increased from 1 to 4+.22 Androgens may regulate HDL cholesterol concentrations in boys during puberty.23 We found that HDL cholesterol concentration clearly decreased more in boys than in girls during puberty. Prepubertal boys had higher HDL cholesterol than prepubertal girls, whereas the situation was the opposite at late puberty.
It has been hypothesized that early nutrition, possibly energy, protein, or fat intake, might influence pubertal development.24 Given that cholesterol is the precursor of sex steroids and that dietary fat intake is one of the major determinants of pubertal development in girls, the slightly higher fat and saturated fat intake by the control girls could hasten their pubertal development, whereas the tempo of pubertal changes in the intervention girls might be slower. In the DISC study, a significant decrease in several serum sex hormones, ie,
30% lower serum estradiol and estrone concentrations, was observed in adolescent girls receiving counseling that suggested lower saturated fat and cholesterol intake compared with girls consuming an unrestricted diet.25 We did not find any differences in the pubertal development in either gender between the 2 study groups. The current mean age of breast budding in Western countries (excluding the United States) is about 11 years, and the mean age of the beginning of testicular growth is
11.5 years.24 Approximately half of the STRIP children had reached these stages by 11 years of age. The STRIP study boys progressed to puberty quite early;
60% of the boys were in Tanner stage 2 at 11 years of age. We used testicular length >20 mm as the indicator of entry into puberty, whereas in other studies, testicular length of 25 mm (
1 inch) has commonly been used.15 This may increase the proportion of boys considered pubertal in the present study. Median age at menarche in STRIP girls was 12.8 to 13.0 years, and it did not differ between the study groups. This age resembles the menarcheal age observed in Western countries lately24 and is a few months earlier than reported in Finland 3 decades ago.26
Conclusions
A low-saturated-fat, low-cholesterol–oriented nutrition intervention had a favorable effect on saturated fat intake and serum total and LDL cholesterol concentrations throughout the first 14 years of life. The lipid-lowering effect was maintained through prepuberty and puberty, when children consume exceedingly more of their dietary intakes away from home. Puberty induced major changes in serum cholesterol and HDL cholesterol values, and the decrease in total cholesterol was clearly greater in boys than girls. Growth and pubertal development remained similar between the intervention and control children. Thus, our present data do not support the fear that saturated fat restriction influences either growth or pubertal timing or tempo in healthy children.
| Acknowledgments |
|---|
The present study was supported by grants from the Finnish Cardiac Research Foundation; Foundation for Pediatric Research, Finland; Academy of Finland (grants 206374, 210238, 77841, 34316); Yrjö Jahnsson Foundation; Sigrid Juselius Foundation; Special Federal Research Funds for Turku University Hospital; Turku University Foundation; Turku University Hospital Foundation; Juho Vainio Foundation; and Finnish Cultural Foundation.
Disclosures
None.
| References |
|---|
|
|
|---|
2. Nicklas TA, Farris RP, Smoak CG, Frank GC, Srinivasan SR, Webber LS, Berenson GS. Dietary factors relate to cardiovascular risk factors early in life: Bogalusa Heart study. Arteriosclerosis. 1988; 8: 193–199.
3. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. JAMA. 1995; 273: 1429–1435.
4. Newman III WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986; 314: 138–144.[Abstract]
5. Raitakari OT, Rönnemaa T, Järvisalo MJ, Kaitosaari T, Volanen I, Kallio K, Lagström H, Jokinen E, Niinikoski H, Viikari JS, Simell O. Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku Coronary Risk Factor Intervention Project for Children (STRIP). Circulation. 2005; 112: 3786–3794.
6. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Åkerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290: 2277–2283.
7. Lapinleimu H, Viikari J, Jokinen E, Salo P, Routi. T, Leino A, Rönnemaa T, Seppänen R, Välimäki I, Simell O. Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet. 1995; 345: 471–476.[CrossRef][Medline] [Order article via Infotrieve]
8. Kaitosaari T, Rönnemaa T, Raitakari O, Talvia S, Kallio K, Volanen I, Leino A, Jokinen E, Välimäki I, Viikari J, Simell O. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized Special Turku Coronary Risk factor Intervention Project for Children (STRIP) study. Circulation. 2003; 108: 672–677.
9. Rask-Nissilä L, Jokinen E, Terho P, Tammi A, Lapinleimu H, Rönnemaa T, Viikari J, Seppänen R, Korhonen T, Tuominen J, Välimäki I, Simell O. Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy: a randomized controlled trial. JAMA. 2000; 284: 993–1000.
10. Viikari J, Åkerblom HK, Nikkari T, Seppänen A, Uhari M, Pesonen E, Dahl M, Lähde PL, Pietikäinen M, Suoninen P. Atherosclerosis precursors in Finnish children and adolescents, IV: serum lipids in newborns, children and adolescents. Acta Paediatr Scand. 1985; 318 (suppl): 103–109.
11. Hakala P, Marniemi J, Knuts L-R, Kumpulainen J, Tahvonen R, Plaami S. Calculated vs. analysed nutrient composition of weight reduction diets. Food Chem. 1996; 57: 71–75.[CrossRef]
12. Kostner GM. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem. 1976; 22: 695. Letter.[Medline] [Order article via Infotrieve]
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499–502.[Abstract]
14. Sorva R, Perheentupa J, Tolppanen EM. A novel format for a growth chart. Acta Paediatr Scand. 1984; 73: 527–529.[Medline] [Order article via Infotrieve]
15. Tanner JM. Growth at Adolescence. 2d ed. Oxford, UK: Blackwell; 1962.
16. Kaitosaari T, Rönnemaa T, Viikari J, Raitakari O, Arffman M, Marniemi J, Kallio K, Pahkala K, Jokinen E, Simell O. Low-saturated fat dietary counseling starting in infancy improves insulin sensitivity in 9-year-old healthy children: the Special Turku Coronary Risk Factors Intervention Project for Children (STRIP) study. Diabetes Care. 2006; 29: 781–785.
17. Hakanen M, Lagström H, Kaitosaari T, Niinikoski H, Näntö-Salonen K, Jokinen E, Sillanmäki L, Viikari J, Rönnemaa T, Simell O. Development of overweight in an atherosclerosis prevention trial starting in early childhood: the STRIP study. Int J Obesity. 2006; 30: 618–626.[CrossRef][Medline] [Order article via Infotrieve]
18. Tammi A, Rönnemaa T, Miettinen T, Gylling H, Rask-Nissilä L, Viikari J, Tuominen J, Marniemi J, Simell O. Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant sterol esters in children: the STRIP study. Acta Paediatr. 2003; 91: 1155–1162.[CrossRef]
19. Pahkala K, Heinonen O-P, Lagström H, Hakala P, Sillanmäki L, Simell O. Leisure-time physical activity of 13-year-old adolescents. Scand J Med Sci Sports. 2007; 17: 324–330.[Medline] [Order article via Infotrieve]
20. Walter HJ, Hofman A, Vaughan RD, Wynder EL. Modification of risk factors for coronary heart disease: five-year results of a school-based intervention trial. N Engl J Med. 1988; 318: 1093–1100.[Abstract]
21. Polonsky SM, Bellet PS, Sprecher DL. Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. Pediatrics. 1993; 91: 92–96.
22. Kwiterovich PO Jr, Barton BA, McMahon RP, Obarzanek E, Hunsberger S, Simons-Morton D, Kimm SY, Friedman LA, Lasser N, Robson A, Lauer R, Stevens V, Van Horn L, Gidding S, Snetselaar L, Hartmuller VW, Greenlick M, Franklin F Jr. Effects of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). Circulation. 1997; 96: 2526–2533.
23. Kirkland RT, Keenan BS, Probstfield JL, Patsch W, Lin TL, Clayton GW, Insull W Jr. Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levels. JAMA. 1987; 257: 502–507.
24. Parent AS, Teilmann G, Juul A, Skakkebaek NE, Toppari J, Bourguignon JP. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev. 2003; 24: 668–693.
25. Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich PO Jr, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR. Diet and sex hormones in girls: findings from a randomized controlled clinical trial. J Natl Cancer Inst. 2003; 95: 132–141.
26. Rimpelä AH, Rimpelä MK. Towards an equal distribution of health? Socioeconomic and regional differences of the secular trend of the age at menarche in Finland from 1979 to 1989. Acta Paediatr. 1993; 82: 87–90.[Medline] [Order article via Infotrieve]
| Footnotes |
|---|
Find additional patient-related information at:
This article has been cited by other articles:
![]() |
J. G Ayer, J. A Harmer, W. Xuan, B. Toelle, K. Webb, C. Almqvist, G. B Marks, and D. S Celermajer Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 y Am. J. Clinical Nutrition, August 1, 2009; 90(2): 438 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Simell, H. Niinikoski, T. Ronnemaa, O. T Raitakari, H. Lagstrom, M. Laurinen, M. Aromaa, P. Hakala, A. Jula, E. Jokinen, et al. Cohort Profile: The STRIP Study (Special Turku Coronary Risk Factor Intervention Project), an Infancy-onset Dietary and Life-style Intervention Trial Int. J. Epidemiol., June 1, 2009; 38(3): 650 - 655. [Full Text] [PDF] |
||||
![]() |
H. Niinikoski, A. Jula, J. Viikari, T. Ronnemaa, P. Heino, H. Lagstrom, E. Jokinen, and O. Simell Blood Pressure Is Lower in Children and Adolescents With a Low-Saturated-Fat Diet Since Infancy: The Special Turku Coronary Risk Factor Intervention Project Hypertension, June 1, 2009; 53(6): 918 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hakanen, O. T. Raitakari, T. Lehtimaki, N. Peltonen, K. Pahkala, L. Sillanmaki, H. Lagstrom, J. Viikari, O. Simell, and T. Ronnemaa FTO Genotype Is Associated with Body Mass Index after the Age of Seven Years But Not with Energy Intake or Leisure-Time Physical Activity J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1281 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kallio, E. Jokinen, M. Hamalainen, M. Saarinen, I. Volanen, T. Kaitosaari, J. Viikari, T. Ronnemaa, O. Simell, and O. T. Raitakari Decreased Aortic Elasticity in Healthy 11-Year-Old Children Exposed to Tobacco Smoke Pediatrics, February 1, 2009; 123(2): e267 - e273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pahkala, O. J. Heinonen, H. Lagstrom, P. Hakala, O. Simell, J. S.A. Viikari, T. Ronnemaa, M. Hernelahti, L. Sillanmaki, and O. T. Raitakari Vascular Endothelial Function and Leisure-Time Physical Activity in Adolescents Circulation, December 2, 2008; 118(23): 2353 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Volanen, K. Kallio, M. Saarinen, M. J. Jarvisalo, R. Vainionpaa, T. Ronnemaa, J. Viikari, J. Marniemi, O. Simell, and O. T. Raitakari Arterial Intima-Media Thickness in 13-Year-Old Adolescents and Previous Antichlamydial Antimicrobial Use: A Retrospective Follow-up Study Pediatrics, September 1, 2008; 122(3): e675 - e681. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Steinberg, C. K. Glass, and J. L. Witztum Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia Circulation, August 5, 2008; 118(6): 672 - 677. [Full Text] [PDF] |
||||
![]() |
J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955. [Full Text] [PDF] |
||||
![]() |
H. C. McGill Jr, C. A. McMahan, and S. S. Gidding Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study Circulation, March 4, 2008; 117(9): 1216 - 1227. [Full Text] [PDF] |
||||
![]() |
S. R. Daniels Diet and Primordial Prevention of Cardiovascular Disease in Children and Adolescents Circulation, August 28, 2007; 116(9): 973 - 974. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |